Policy Notices

• OMB Approval for Grant Application and Related Forms Underway Continue to Use Current Forms (FORMS-E) through May 24, 2020
  (NOT-OD-20-047)
  National Institutes of Health
  Agency for Healthcare Research and Quality
  

General Notices

• UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding
  (NOT-OD-20-018)
  Office of AIDS Research
  

• Request for Information (RFI): ClinicalTrials.gov Modernization
  (NOT-LM-20-003)
  National Library of Medicine
  

Notice of Changes to Funding Opportunities

• Notice of early expiration of e RFA-PAR-16-099 NARMS Cooperative Agreement to Enhance and Strengthen Antimicrobial Resistance Surveillance in Retail Food Specimens (U01)
  (NOT-FD-20-007)
  Food and Drug Administration
  

• Notice of Participation of NIMH in PAR-19-343, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00) Independent CT not Allowed)
  (NOT-MH-20-015)
  National Institute of Mental Health
  

• Notice of Participation of NIMH in PAR-19-342, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)
  (NOT-MH-20-017)
  National Institute of Mental Health
  

• Notice of Change to the Data and Safety Monitoring Plan for PAR-18-422 "NINDS Efficacy Clinical Trials (U01 Clinical Trial Required)
  (NOT-NS-20-013)
  National Institute of Neurological Disorders and Stroke
  

• Notice of NINDS Participation in PA-18-917 "Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)"
  (NOT-NS-20-036)
  National Institute of Neurological Disorders and Stroke
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Modeling Social Contagion of Substance Use Epidemics
  (NOT-DA-20-009)
  National Institute on Drug Abuse
  

• Notice of Special Interest: Administrative Supplement for Research on Bioethical Issues (Admin Supp Clinical Trial Optional)
  (NOT-OD-20-038)
  National Institutes of Health
  Food and Drug Administration
  John E. Fogarty International Center
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health
  

• Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars
  (NOT-OD-20-054)
  National Institutes of Health
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

Funding Opportunities

• Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed)
  (PAR-20-055)
  National Institute of Mental Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is February 5, 2020.
  
  

• Surgical Disparities Research (R01 - Clinical Trial Optional)
  (PAR-20-079)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  Application Receipt Date(s): New Applications: June 5, 2020,; June 5, 2021, June 5, 2022. Resubmission/revision applications: July 5, 2020, July 5, 2021, July 5, 2022.
  
  

• Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)
  (PAR-20-082)
  National Institute of Mental Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is February 16, 2020.
  
  

• Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01 Clinical Trial Required)
  (RFA-DK-19-021)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): March 26, 2020
  
  

• Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed)
  (RFA-DK-19-024)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): April 1, 2020
  
  

• New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)
  (RFA-DK-19-026)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): March 25, 2020 and November 3, 2020
  
  

• Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01 Clinical Trial Optional)
  (RFA-DK-19-029)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): April 7, 2020
  
  

• BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional)
  (RFA-NS-20-006)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  Application Receipt Date(s): March 24, 2020, June 2, 2020, October 1, 2020, February 2, 2021, June 1, 2021, February 1, 2022, and October 3, 2022
  
  

• White Matter Lesion Etiology of Dementia in the U.S. Including in Health Disparity Populations (U19 Clinical Trial not Allowed)
  (RFA-NS-20-013)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): June 30, 2020